Epidemiology, risk factors and prevalence of maternal and neonatal outcomes with critical care requirements in hypertensive disorders of pregnancy: a prospective observational study

Authors

  • Preyas S. Maniar Sal Institute of Pharmacy, Ahmedabad, Gujarat, India
  • Vishruti V. Patel Sal Institute of Pharmacy, Ahmedabad, Gujarat, India https://orcid.org/0009-0005-8307-0489
  • Jeel H. Patel Sal Institute of Pharmacy, Ahmedabad, Gujarat, India https://orcid.org/0009-0001-3246-0621
  • Spruha Thakkar Department of Obstetrics and Gynecology, GMERS Medical College and Hospital, Sola, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20263982

Keywords:

Hypertensive disorders of pregnancy, Pre-eclampsia, ICU and NICU Admissions, Maternal complications, Neonatal outcomes

Abstract

Background: Hypertensive disorders of pregnancy (HDP) remain a leading cause of maternal and neonatal morbidity and mortality worldwide. This study examined maternal and neonatal outcomes across the different HDP subtypes and identified factors linked to ICU and NICU admission.

Methods: In this prospective observational analytical study, 144 pregnant women diagnosed with gestational hypertension, non-severe pre-eclampsia, severe pre-eclampsia, eclampsia, chronic hypertension, or superimposed pre-eclampsia (as defined by FOGSI guidelines) were enrolled. Maternal characteristics, maternal complications, ICU admission, neonatal complications, NICU admission, and mortality were recorded from hospital records. Data were analyzed using the Chi-square test, Fisher’s Exact test, multivariate logistic regression, odds ratio estimation, and ROC curve analysis.

Results: Severe pre-eclampsia and superimposed pre-eclampsia emerged as independent predictors of maternal ICU admission, while eclampsia and superimposed pre-eclampsia independently predicted NICU admission. Maternal ICU admission was strongly linked to neonatal NICU admission (χ2=13.09, p<0.001). The predictive model performed well, with an AUC of 0.8789, sensitivity of 83.6%, and specificity of 85.7%.

Conclusions: Severe HDP subtypes carry a substantially higher risk of adverse maternal and neonatal outcomes. Early recognition, close monitoring, and timely intervention remain central to improving prognosis in hypertensive pregnancies.

References

Bączkowska M, Kosinska-Kaczynska K, Zgliczynska M, Brawura-Biskupski-Samaha R. Epidemiology, risk factors, and perinatal outcomes of placental abruption- detailed annual data and clinical perspectives from Polish tertiary center. Int J Environ Res Public Health. 2022;19(9):5148.

Mohanty S, Pradhan M, Champatiray JR, Ganguly S. Neonatal outcome in hypertensive disorders of pregnancy in a tertiary care centre. Panacea J Med Sci. 2022;12(1):23-8.

Vera-Ponce VJ, Loayza-Castro JA, Ballena-Caicedo J, Valladolid-Sandoval LA, Zuzunaga-Montoya FE, Gutierrez De Carrillo CI. Global prevalence of preeclampsia, eclampsia, and HELLP syndrome: a systematic review and meta-analysis. Front Reprod Health. 2025;7:1706009.

Panda S, Das R, Sharma N, Das A, Deb P, Singh K. Maternal and perinatal outcomes in hypertensive disorders of pregnancy and factors influencing it: A prospective hospital-based study in Northeast India. Cureus. 2021;13(3):e13982.

Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens. 2010;24(2):104-10.

Bucher V, Roddy Mitchell A, Gudmundsson P, Atkinson J, Wallin N, Asp J, et al. Prediction of adverse maternal and perinatal outcomes associated with pre-eclampsia and hypertensive disorders of pregnancy: a systematic review and meta-analysis. eClinMed. 2024;76:102861.

Rocha FR, Gonçalves TN, Xavier-Ferreira MI, Laranjeira F, Magalhães GM, Lopes MI, et al. Obstetric intensive care admissions and neonatal outcomes: 15 years of experience from a single center. Medicina. 2024;60(12):1937.

Subki AH, Algethami MR, Baabdullah WM, Alnefaie M, Alzanbagi MA, Alsolami RM, et al. (2018). Prevalence, risk factors, and fetal and maternal outcomes of hypertensive disorders of pregnancy: A retrospective study in Western Saudi Arabia. Oman Med J. 2018;33(5):409-15.

Jain S, Mor S, Jain M, Shivkumar PV, Mittal G. Feto-maternal outcomes in hypertensive disorders of pregnancy: A prospective community-based cohort study in rural central India. Pregnancy Hypertens. 2026;44:101481.

Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Pregnancy Childbirth. 2021;21(1):364.

Pembe AB, Dwarkanath P, Kikula A, Raj JM, Perumal N, Paulo HA, et al. Hypertensive disorders of pregnancy and perinatal outcomes: two prospective cohort studies of nulliparous women in India and Tanzania. BMJ Glob Health. 2025;10(7):e016339.

Yousofzai BS, Walizada K, Mehmood R, Latoui RB, Subhan M, Espiegle E, et al. Maternal and neonatal outcomes in pregnant women with chronic hypertension: a retrospective study of 50 cases. Cureus. 2024;16(9).

Chen W. (2026). A prospective study on maternal and neonatal outcomes and influencing factors in pregnant women with borderline hypertension. J Matern Fet Neonat Med. 2026;39(1),

Traub A, Sharma A, Gongora MC. (2024). Hypertensive disorders of pregnancy: A literature review- pathophysiology, current management, future perspectives, and healthcare disparities. US Cardiol Rev. 2024;18:e03.

Mathew R, Devanesan BP, Srijana, Sreedevi NS. Prevalence of hypertensive disorders of pregnancy, associated factors and pregnancy complications in a primigravida population. Gynecol Obstet Clin Med. 2023;3(2):119-23.

Schaefer V, Hilfiker-Kleiner D, Keil C. Hypertension in pregnancy. Cardiovasc Med. 2023;26(3):80.

Kole U, Raddi SA, Dalal A. (2022). Maternal and neonatal outcomes in hypertensive disorders during pregnancy: A hospital-based study. Indian J Phys Ther Res. 2022;4(2):127-32.

Sitharam S. (2022). Maternal and perinatal outcome in hypertensive disorders of pregnancy in a tertiary care rural hospital. Southeast Asian J Case Rep Rev. 2022;8(1):21-5.

Dhinwa M, Gawande K, Jha N, Anjali M, Bhadoria AS, Sinha S. Prevalence of hypertensive disorders of pregnancy in India: a systematic review and meta-analysis. J Med Evid 2021;2(2):105-12.

Lakhute SV, Kendre V, Dixit J. A study of epidemiological factors in antenatal mothers with pregnancy-induced hypertension at the tertiary care hospital. Med J Dr. D. Y. Patil Vidyapeeth. 2021;14(1):52-6.

Shrestha DB, Budhathoki P, Malbul K, Katwal S, Jha SK, Prajapati R, et al. Prevalence, risk factors and outcome of pregnancy induced hypertension in Nepal: a meta-analysis of prevalence studies. J Nepal Health Res Council. 2021;19(2):221-9.

Sengodan SS, Sreeprathi N. Prevalence of hypertensive disorders of pregnancy and its maternal outcome in a tertiary care hospital, Salem, Tamil Nadu, India. Int J Reprod Contracept Obstet Gynecol. 2019;9(1):236-40.

Das S, Sahu M, Mohapatra S, Padmavati VM, Panigrahi PK. Pregnancy induced hypertension and feto-maternal outcome in a tertiary care hospital in eastern India: A Prospective Study. J Clin Diagn Res. 2018;12(11).

Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: Prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213-20.

Shamsi U, Saleem S, Nishter N, Ameen A. Epidemiology and risk factors of preeclampsia; an overview of observational studies. Al Ameen J Med Sci. 2013;6(4):292-300.

Downloads

Published

2026-10-29

How to Cite

Maniar, P. S., Patel, V. V., Patel, J. H., & Thakkar, S. (2026). Epidemiology, risk factors and prevalence of maternal and neonatal outcomes with critical care requirements in hypertensive disorders of pregnancy: a prospective observational study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 15(11), 4386–4392. https://doi.org/10.18203/2320-1770.ijrcog20263982

Issue

Section

Original Research Articles